ask="4.3200"
ask_size="300"
average_daily_volume="179615"
bid="1.9500"
bid_size="500"
book_value="3.4050"
change="-0.0001"
change_from_200_day_moving_average="-0.4147"
change_from_50_day_moving_average="-0.0936"
change_from_52_week_high="-4.4401"
change_From_52_week_low="1.0998"
change_in_percent="-0.0034%"
close="2.9499"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-7.4870"
ebitda="-7.62M"
eps_estimate_current_year="-1.1800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-1.2700"
ex_dividend_date="N/A"
float_shares="2302000"
high="2.9900"
high_52_weeks="7.3900"
last_trade_date="2/22/2017"
last_trade_price="2.9499"
last_trade_size="200"
last_trade_time="3:54pm"
low="2.9300"
low_52_weeks="1.8501"
market_capitalization="29.16M"
moving_average_200_day="3.3646"
moving_average_50_day="3.0435"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.0000"
open="2.9500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-12.3254%"
percent_change_from_50_day_moving_average="-3.0764%"
percent_change_from_52_week_high="-60.0825%"
percent_change_from_52_week_low="+59.4454%"
previous_close="2.9500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8664"
price_per_sales="2.1469"
revenue="13.58M"
shares_outstanding="9886000"
short_ratio="3.8600"
stock_exchange="NCM"
symbol="KOOL"
volume="27081"
weeks_range_52="1.8501 - 7.3900"
